Protein glycosylation and diseases: blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring.
about
GRASPs in Golgi Structure and FunctionProteomics and mass spectrometry for cancer biomarker discoverySerum Glycopatterns as Novel Potential Biomarkers for Diagnosis of Acute-on-Chronic Hepatitis B Liver FailureA pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines.Natural-product sugar biosynthesis and enzymatic glycodiversification.Label-free measuring and mapping of binding kinetics of membrane proteins in single living cellsSelective isolation of glycoproteins and glycopeptides for MALDI-TOF MS detection supported by magnetic particles.Analysis of glycoproteins in human serum by means of glycospecific magnetic bead separation and LC-MALDI-TOF/TOF analysis with automated glycopeptide detection.Development of IgA nephropathy-like glomerulonephritis associated with Wiskott-Aldrich syndrome protein deficiency.Optimizing performance of glycopeptide capture for plasma proteomicsAnalysis of age and gender associated N-glycoproteome in human whole saliva.Analysis of N-glycoproteins using genomic N-glycosite prediction.Protein biomarkers in cancer: natural glycoprotein microarray approachesA program for ligation at threonine sites: application to the controlled total synthesis of glycopeptides.A survey of membrane proteins in human serumSolid-phase extraction of N-linked glycopeptides.Sialic acid-focused quantitative mouse serum glycoproteomics by multiple reaction monitoring assay.Selected reaction monitoring to differentiate and relatively quantitate isomers of sulfated and unsulfated core 1 O-glycans from salivary MUC7 protein in rheumatoid arthritis.Measurement of glycosylated alpha-fetoprotein improves diagnostic power over the native form in hepatocellular carcinomaMapping tissue-specific expression of extracellular proteins using systematic glycoproteomic analysis of different mouse tissues.Glycoproteomics for prostate cancer detection: changes in serum PSA glycosylation patterns.Increased N-glycosylation of Asn⁸⁸ in serum pancreatic ribonuclease 1 is a novel diagnostic marker for pancreatic cancerJacalin bound plasma O-glycoproteome and reduced sialylation of alpha 2-HS glycoprotein (A2HSG) in rheumatoid arthritis patientsSimultaneous analysis of glycosylated and sialylated prostate-specific antigen revealing differential distribution of glycosylated prostate-specific antigen isoforms in prostate cancer tissuesThe affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypes.N-glycomic changes in serum proteins in type 2 diabetes mellitus correlate with complications and with metabolic syndrome parameters.Direct and rapid mass spectral fingerprinting of maternal urine for the detection of Down syndrome pregnancyA peptide N-terminal protection strategy for comprehensive glycoproteome analysis using hydrazide chemistry based method.Targeted mass spectrometric approach for biomarker discovery and validation with nonglycosylated tryptic peptides from N-linked glycoproteins in human plasmaGPQuest: A Spectral Library Matching Algorithm for Site-Specific Assignment of Tandem Mass Spectra to Intact N-glycopeptides.Identification of glycoproteins containing specific glycans using a lectin-chemical method.Identification of glycoprotein markers for pancreatic cancer CD24+CD44+ stem-like cells using nano-LC-MS/MS and tissue microarray.Recognition of N-glycoforms in human chorionic gonadotropin by monoclonal antibodies and their interaction motifs.Toward deciphering proteomes of formalin-fixed paraffin-embedded (FFPE) tissues.Associations Between the Serum Metabolome and All-Cause Mortality Among African Americans in the Atherosclerosis Risk in Communities (ARIC) Study.Targeting inhibition of GluR1 Ser845 phosphorylation with an RNA aptamer that blocks AMPA receptor trafficking.Efficacy of glycoprotein enrichment by microscale lectin affinity chromatography.Characterization of disease-associated N-linked glycoproteinsClassification of Tandem Mass Spectra for Identification of N- and O-linked Glycopeptides.Comparison of biological activities of human antithrombins with high-mannose or complex-type nonfucosylated N-linked oligosaccharides.
P2860
Q26771341-6AFAA13F-025F-4747-A278-3F45AAA8C377Q28766969-9359866B-1C18-4C81-8AFA-4A7B6410299FQ30358956-FF343F13-7EBD-442E-B0C6-EB95E3A312EEQ30368704-584A9AEE-8004-448B-8D20-ED114A9E371EQ30492476-12FB13B4-69E0-45D3-880C-1FA47D2E1286Q30539992-B3528BAD-2E50-41EB-95EB-6D4A6F4E29C0Q33235741-CD078703-7133-499F-9B1B-209BDB25E014Q33301622-0DECE193-7592-4ED1-B5CD-D0826D89A768Q33398196-514FBC4F-84FA-4AAF-8E36-128585F2CFB8Q33794498-9B8C46DD-8035-4AA2-ACF7-659127E5DC60Q33804518-A9F05475-4F9B-44D1-B8A7-9D4F7076826DQ33810938-7410935E-DA9F-402D-960A-F7F6B5AFEB08Q34062987-AB53233F-063B-4589-9F4E-3564FB102239Q34078234-97342346-221C-4176-AD07-16160F806A99Q34254384-5FE5ACA5-54E4-4892-B5A0-677E60A52E98Q34271181-DA024CAD-5EAC-4B77-9BE2-3D7E7CFD090CQ34320706-665A8139-D4FD-4E09-A817-C322F182582DQ34330811-43E901ED-6691-4F61-94DD-9A25EA13E3A8Q34332296-0B3D2D13-CED8-4BFE-9925-31A2946FBF34Q34336108-48CCD2B0-02C2-4D0E-80BA-064708040D9AQ34381513-FDA8AE5C-891A-4ED0-969A-20A76228CBEAQ34385175-BEF89065-3E40-4142-A4CE-3B4C3F6B5D08Q34441384-2C36A8D3-080E-44C0-BCD4-39E4E1E24D96Q34541208-37617631-112C-4113-A36B-7C32055087B1Q35103730-BFE52306-D091-47DA-8DDA-F6EE9EDA10F4Q35201538-C1DAB824-50A2-46B1-B158-2EDCECFA6AD2Q35312739-9C92FFE5-B9B2-4062-93B2-AC5DDFE96C33Q35591012-7BFEF50E-4B98-4F87-94DD-EEBAE11FA488Q35610651-8A931309-D9D6-446B-B087-70D52A9682FDQ35623058-130F93A6-A989-43E9-9801-EF58C40EA1C5Q35833266-A6655500-1FFE-450C-8AD0-C4652158516DQ35874854-171E89E9-21A8-4FDF-A957-45DEED4D467CQ36050006-4FFCB942-B2F5-41A8-AD09-7928308B1B1BQ36580016-3C06E603-1856-4AD7-A16B-9130C165B52AQ36710093-7B3337BD-381F-4744-B759-5E7436860787Q36795825-95389F96-5D7F-42E5-9EF2-1519A45AF295Q36857295-BE0000C9-22E0-4A06-8F32-FAC4A1F4ED54Q37069869-D522961E-1452-4C46-BBCF-E11FD3D749DEQ37424917-3683E283-FC78-4616-87D0-89D0298D7205Q38294435-FD29383A-14B1-40A5-9CA2-6205FEE617E9
P2860
Protein glycosylation and diseases: blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Protein glycosylation and dise ...... is and therapeutic monitoring.
@ast
Protein glycosylation and dise ...... is and therapeutic monitoring.
@en
type
label
Protein glycosylation and dise ...... is and therapeutic monitoring.
@ast
Protein glycosylation and dise ...... is and therapeutic monitoring.
@en
prefLabel
Protein glycosylation and dise ...... is and therapeutic monitoring.
@ast
Protein glycosylation and dise ...... is and therapeutic monitoring.
@en
P1433
P1476
Protein glycosylation and dise ...... is and therapeutic monitoring.
@en
P304
P407
P433
P577
2000-06-01T00:00:00Z